Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,945.00
-15.00 (-0.51%)
At close: Aug 8, 2025, 3:30 PM KST

Biotoxtech Company Description

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea.

It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development.

The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity test, immunotoxicity test, safety pharmacology test, aquatic ecotoxicology test, histopathology/clinical pathology, and animal testing method.

Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.

Biotoxtech Co., Ltd.
CountrySouth Korea
Founded2000
IndustryMedical Laboratories
Employees198
CEOJong-Koo Kang

Contact Details

Address:
Ochang Science Industrial Complex
Cheongwon, Chungcheongbuk-do 363-883
South Korea
Phone82 4 3210 7777
Websitebiotoxtech.com

Stock Details

Ticker Symbol086040
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code8071

Key Executives

NamePosition
Jong-Koo KangChief Executive Officer